Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$82.6K Buy
228
+7
+3% +$2.4K 0.05% 214
2026
Q1
$77.8K Buy
221
+32
+17% +$11.4K 0.06% 187
2025
Q4
$61.9K Sell
189
-2
-1% -$634 0.05% 246
2025
Q3
$53.9K Buy
191
+2
+1% +$580 0.04% 276
2025
Q2
$52.8K Sell
189
-199
-51% -$56.4K 0.04% 261
2025
Q1
$121K Sell
388
-192
-33% -$56.7K 0.11% 136
2024
Q4
$151K Buy
+580
New +$172K 0.14% 124

Other funds holding AMGN

WPG Advisers's AMGN Position: Q2 2026 in Review

WPG Advisers increased its Amgen (AMGN) stake by 3.2% in Q2 2026, buying an estimated $2.4K and bringing the position to 228 shares worth $82.6K. The position accounts for 0.05% of the portfolio, ranked #214.

WPG Advisers first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $151K in Q4 2024. 2,083 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • WPG Advisers held 228 shares of Amgen worth $82.6K as of Q2 2026.
  • WPG Advisers bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.05% of WPG Advisers's portfolio in Q2 2026, its #214 holding.
  • WPG Advisers first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Amgen position peaked at $151K in Q4 2024.
  • 2,083 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.